CVS Health (NYSE: CVS) reported Q2 EPS of $1.33, $0.02 better than the analyst estimate of $1.31. Revenue for the quarter came in at $45.7 billion versus the consensus estimate of $45.37 billion.

Comps decline 2.6%

GUIDANCE:

CVS Health sees FY2017 EPS of $5.83-$5.93, versus the consensus of $5.87.

For earnings history and earnings-related data on CVS Health (CVS) click here.